Rationale and methodology of the impact of continuous positive airway pressure on patients with ACS and nonsleepy OSA: The ISAACC trial

Clinical Cardiology

Volumn 36, Issue 9, 2013, Pages 495-501

  Esquinas, Cristina ^a,c   Sánchez De La Torre, Manuel ^b,c   Aldomá, Albina ^a   Florés, Marina ^a   Martínez, Montserrat ^c   Barcelõ, Antonia ^b,d   Barbé, Ferran ^a,b,c  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF LLEIDA   (Spain)

^d HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; APNEA HYPOPNEA INDEX; ARTICLE; CARDIORESPIRATORY POLYGRAPHY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PROCEDURE; CEREBROVASCULAR ACCIDENT; CONSERVATIVE TREATMENT; CORONARY CARE UNIT; COST EFFECTIVENESS ANALYSIS; DAYTIME SOMNOLENCE; DIABETES MELLITUS; EPWORTH SLEEPINESS SCALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; INCIDENCE; OPEN STUDY; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PROSPECTIVE STUDY; QUALITY OF LIFE; SLEEP DISORDERED BREATHING; TEACHING HOSPITAL; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ADULT; AGED; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; SPAIN; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84883865909     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22166     Document Type: Article

References (35)

1. Punjabi NM,. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008; 5: 136-143.
2. Duran J, Esnaola S, Rubio R, et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001; 163: 685-689.
3. Giles TL, Lasserson TJ, Smith BH, et al. Continuous positive pressure form obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006; 3:CD001106.
4. McDaid C, Griffin S, Weatherly H, et al. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technol Assess. 2009; 13: iii-xiv, 1.
5. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004; 110: e82-e292.
6. Konecny T, Sert Kuniyoshi F, Oban M, et al. Under-diagnosis of sleep apnea in patients after acute myocardial infarction. J Am Coll Cardiol. 2010; 9: 742-746.
7. Schitza S, Simantirakis E, Bouloukaki, I, et al. Sleep disordered breathing in patients with acute coronary syndromes. J Clin Sleep Med. 2012; 8: 21-26.
8. Mehra R, Principe-Rodriguez K, Kirchner HL, et al. Sleep apnea in acute coronary syndrome: high prevalence but low impact on 6-month outcome. Sleep Med. 2006; 7: 521-528.
9. Sánchez-de-la-Torre M, Campos-Rodriguez F, Barbé F., Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med. 2012;doi:10.1016/S2213-2600(12) 70051-6.
10. Gami AS, Howard DE, Olson EJ, et al. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med. 2005; 352: 1206-1214.
11. Kuniyoshi FH, Garcia-Touchard A, Gami AS, et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol. 2008; 52: 343-346.
12. Bradley TD, Floras JS,. Obstructive sleep apnoea and its cardiovascular consequences. Lancet. 2009; 373: 82-93.
13. Mooe T, Franklin KA, Wiklund U, et al. Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. Chest. 2000; 117: 1597-1602.
14. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365: 1046-1053.
15. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995; 96: 1897-1904.
16. Franklin KA, Nilsson JB, Sahlin C, et al. Sleep apnoea and nocturnal angina. Lancet. 1995; 345: 1085-1087.
17. Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007; 49: 1625-1631.
18. Arõs F, Marrugat J, Lõpez-Bescos L, et al. Accessibility to coronary angiography and one-year survival after myocardial infarction. Am J Cardiol. 2002; 90: 409-412.
19. Yumino D, Tsurumi Y, Takagi A, et al. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol. 2007; 99: 26-30.
20. Correia LC, Souza AC, Garcia G, et al. Obstructive sleep apnea affects hospital outcomes of patients with non-ST-elevation acute coronary syndromes. Sleep. 2012; 35: 1241-1245.
21. Tkacova R, Rankin F, Fitzgerald FS, et al. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation. 1998; 98: 2269-2275.
22. Barbé F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: a randomized, controlled trial. Ann Intern Med. 2001; 134: 1015-1023.
23. Barbé F, Durán-Cantolla J, Capote F, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010; 181: 718-726.
24. Peker Y, Glantz H, Thunström E, et al. Rationale and design of the Randomized Intervention with CPAP in Coronary Artery Disease and Sleep Apnoea-RICCADSA trial. Scand Cardiovasc J. 2009; 43: 24-31.
25. Bradley TD, Logan AG, Kimoff RJ, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med. 2005; 353: 2025-2033.
26. Büchner NJ, Sanner BM, Borgel J, et al. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med. 2007; 176: 1274-1280.
27. Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012; 307: 2161-2168.
28. Mc Evoy RD, Anderson CS, Antic NA, et al. The sleep apnea cardiovascular endpoints (SAVE) trial: rationale and start-up phase. J Thorac Dis. 2010; 2: 138-143.
29. Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013; 158: 200-207.
30. Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010; 152: 726-732.
31. Deckers JW., Classification of myocardial infarction and unstable angina: a re-assessment. Int J Cardiol. 2013;doi:10.1016/j.ijcard.2013.01.008.
32. Spanish National Consensus in Sleep Apnea-Hypopnea Syndrome (SAHS) [article in Spanish]. Arch Bronconeumol. 2005; 41: 7-9.
33. Campos-Rodriguez F, Martinez-Garcia MA, Martinez M, et al. Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort. Am J Respir Crit Care Med. 2013; 187: 99-105.
34. Chiner E, Arriero JM, Signes-Costa J, et al. Validation of the Spanish version of the Epworth Sleepiness Scale in patients with a sleep apnea syndrome [article in Spanish]. Arch Bronconeumol. 1999; 35: 422-427.
35. Masa JF, Jiménez A, Durán J, et al. Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am J Respir Crit Care Med. 2004; 170: 1218-1224.